China · Delayed Price · Currency is CNY Shanghai Medicilon Company Description
Shanghai Medicilon Inc., a contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally.
The company operates through Drug Discovery and Pharmaceutical Research, and Preclinical Research segments.
It offers medicinal and analytical chemistry; process development services; custom and zoom in synthesis; structural, in vitro, and computational biology; protein expression and purification; protein crystallization; and recombinant kinase preparation services, as well as protein target validation, compound activity screening and optimization, raw material and preparation process research, and quality standards and stability research.
The company also provides process route screening, API production process optimization, drug process research and application, pharmacology services, drug safety evaluation, biological analysis, IND filing, and TCM preclinical trial service solutions, such as pharmaceutical research, pharmacodynamics, pharmacokinetics, and toxicology.
In addition, it provides efficient lipid synthesis, liposome preparation, prescription screening, process optimization and development, quality research, safety evaluation, bioanalysis, registration and declaration, etc.; pre-formulation research, drug analysis, drug stability research, and formulation development; and cytokine and biomarker testing, bioanalysis, and flow cytometry service, as well as assists in the research and development of new drugs.
Further, the company is involved in molecular type drug development activities. Shanghai Medicilon Inc. was founded in 2004 and is headquartered in Shanghai, China.
| Country | China |
| Founded | 2004 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2,349 |
| CEO | Chunlin Chen |
Contact Details
Address: No. 585, Chuanda Road Shanghai, 201299 China | |
| Phone | 86 21 5859 1500 |
| Website | medicilon.com.cn |
Stock Details
| Ticker Symbol | 688202 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003NQ8 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Jianglin Hu | Joint Chief Executive Officer, Executive Vice President and Chief Strategy and Development Officer |
| Dr. Chun-Lin Chen Ph.D. | Co-Founder, Chairman and Chief Executive Officer |
| Shuangqing Peng Ph.D. | Chief Scientific Officer |
| Dr. Jinna Cai Ph.D. | Chief Commercial Officer, Deputy GM and Director |
| Binbin Liu | Deputy General Manager |
| Donghua Zhang | Financial Director |
| Dr. Lilly Xu Ph.D. | Chief Technology Officer |
| Jiang Xu MBA | Manager of Human Resources Department |
| Dr. Haizhou Zhang | President of Preclinical Research & Development Unit |
| Dr. Qingcong Lin | Deputy GM and Director |